SE Come
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Cancer Risks and Factors 2
- Cancer survivorship and care 2
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- S. Gertler (1 shared paper)Aman U. Buzdar (1 shared paper)Matthew J. Ellis (1 shared paper)C. Kent Osborne (1 shared paper)John Pippen (1 shared paper)Richard Elledge (1 shared paper)Alan Webster (1 shared paper)L M Parker (1 shared paper)
- Journals
- Cancer Research (8 papers)Journal of Clinical Oncology (5 papers)Annals of Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
SE Come
19 papers receiving 623 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 212
- Oncology 324
- Genetics 322
- Pulmonary and Respiratory Medicine 191
- Toxicology 6
Countries citing papers authored by SE Come
This map shows the geographic impact of SE Come's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SE Come with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SE Come more than expected).
Fields of papers citing papers by SE Come
This network shows the impact of papers produced by SE Come. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SE Come. The network helps show where SE Come may publish in the future.
Co-authors
The 25 scholars most cited alongside SE Come, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 465 | |
| 2 | New agents and new medical treatments for advanced breast cancer. | 1987 | 47 |
| 3 | 2011 | 30 | |
| 4 | 2001 | 28 | |
| 5 | 2013 | 24 | |
| 6 | 2011 | 12 | |
| 7 | 2019 | 12 | |
| 8 | 2001 | 10 | |
| 9 | 1995 | 7 | |
| 10 | 2019 | 3 | |
| 11 | 2011 | 3 | |
| 12 | 2016 | 2 | |
| 13 | 2009 | 2 | |
| 14 | 2011 | 2 | |
| 15 | 2010 | 2 | |
| 16 | 2018 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2009 | 1 | |
| 19 | 2011 | 1 |
About SE Come
SE Come is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Surgery, having authored 19 papers that have together received 653 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (5 papers), Estrogen and related hormone effects (3 papers), Cancer Genomics and Diagnostics (3 papers), BRCA gene mutations in cancer (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Risks and Factors (2 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Cancer Research (212 citations), Oncology (324 citations), Genetics (322 citations), Pulmonary and Respiratory Medicine (191 citations) and Toxicology (6 citations). SE Come has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include S. Gertler, Aman U. Buzdar, Matthew J. Ellis, C. Kent Osborne, John Pippen, Richard Elledge, Alan Webster, L M Parker, Charles Morris and G. Burton. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.